The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents

摘要 本会议拨款申请请求资金帮助支持第22届国际会议 2019年卡波西肉瘤疱疹病毒及相关药物会议。我们一年一度的 会议将汇集研究致癌人类的研究人员和临床医生 疱疹病毒、卡波西氏肉瘤疱疹病毒(KSHV)和其他密切相关的病原体。这个 资金将用于降低尚未完成的美国会议前和会议后的注册费用 博士生、历史上代表性不足的少数民族和来自贫穷国家的科学家 研究致癌DNA病毒的人。这些会议的目标与使命是一致的 NIH、NCI、NIAID和NIDCR的声明，即推进和促进 与人类癌症和其他疾病有关的感染研究，包括在 艾滋病毒-艾滋病的背景。KSHV会议将在纽约市举行，将于 2019年6月30日晚至7月3日上午。所有这些的剩余成本 会议将从与会者支付的注册费和来自以下方面的捐款中筹集 主办机构、基金会以及制药和生物技术公司。主 KSHV会议的焦点是致癌疱疹病毒的生物学和相关的人类 疾病，特别强调病毒的致病机理、病毒潜伏和重新激活、病毒基因 表达和复制，宿主对感染的反应，流行病学，疫苗开发， 和治疗性干预。除了KSHV，与疱疹病毒SAIMIRI(HVS)相关的研究， 将介绍小鼠疱疹病毒-68(MHV-68)和恒河猴流感病毒(RRV)。22日 卡波西肉瘤相关疱疹病毒及相关药物国际会议 这是病毒发现25周年。 好了！ 好了！

ABSTRACT This conference grant application requests funds to help support the 22nd International Conference on Kaposi's Sarcoma Herpesvirus and Related Agents in 2019. Our annual conference will bring together researchers and clinicians working on the oncogenic human herpesvirus, Kaposi's sarcoma herpesvirus (KSHV), and other closely related pathogens. The funds will be used to reduce the conference registration costs for outstanding US pre- and post- doctoral trainees, historically under-represented minorities, and scientists from poor countries who study oncogenic DNA viruses. The goals of these meetings are consistent with the mission statements of the NIH, NCI, NIAID, and NIDCR, namely, to advance and promote the pace of research on infections associated with human cancer and other diseases, including in the setting of HIV-AIDS. The KSHV conference will be held in New York City and will occur from the evening of June 30 through the morning of July 3, 2019. All remaining costs for these conferences will be raised from registration fees paid by the conferees and contributions from host institutions, foundations, and pharmaceutical and biotechnology companies. The main focus of the KSHV meeting is the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, and therapeutic intervention. In addition to KSHV, studies related to herpesvirus saimiri (HVS), murine herpesvirus-68 (MHV-68), and rhesus rhadinovirus (RRV) will be presented. The 22nd International Conference on Kaposi's Sarcoma-Associated Herpesvirus and Related Agents is the 25th anniversary of the virus's discovery. ! !